Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

New Zeria compounds with alpha1-adrenoceptor-blocking effects

Feb. 1, 2000

OPC-41061 + furosemide: additive diuretic effect + beneficial effect on electrolytes

Jan. 31, 2000

Bayer presents new candidate treatment for ED at ESIR

Jan. 31, 2000

IC-351 improves erectile response to visual stimulation in men with mild to moderate ED

Jan. 31, 2000

New formulation of Xatral receives European approvals

Jan. 28, 2000

Takeda files for ED treatment in Europe

Jan. 27, 2000

Novel, highly water soluble salt of sildenafil suitable for intranasal administration

Jan. 26, 2000

New inhibitors of cGMP-PDE in development at BMS for ED and cardiovascular conditions

Jan. 24, 2000

Melanocortin receptor agonists and their use disclosed by Merck

Jan. 21, 2000

Afferon steps up development of RTX for treatment of urge incontinence

Jan. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...